Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.35p
   
  • Change Today:
    -0.050p
  • 52 Week High: 5.34
  • 52 Week Low: 1.60
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 1,287,198
  • Market Cap: £24.48m
  • Beta: 0.05

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -71.1% -16.4%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.8 0.6
Pr/Book n/a  
Latest F'cast
Revenue 145.9% 35.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

STX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 5.50 (49.43) (21.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 13.09 (32.38) (5.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 32.18 (26.56) (3.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 43.75 (7.16) (64.25)p n/a n/a n/a n/a 0.0%
31-Dec-26 60.67 0.67 (8.01)p n/a n/a n/a n/a 0.0%
31-Dec-27 92.31 17.68 3.00p 0.8 n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

STX Company Announcements

Audited results for the year ended 31 Dec 2024 24-Apr-2025 07:06 RNS
Licence Agreement in Japan for ACCRUFeR® 22-Apr-2025 07:01 RNS
Q1 2025 Trading Update 17-Apr-2025 11:23 RNS

STX ShareCast News

Shield Therapeutics inks exclusive licence agree... 22-Apr-2025 ShareCast
Shield Therapeutics appoints Anders Lundstrom as... 27-Jan-2025 ShareCast
Shield Therapeutics secures $10m investment, ann... 06-Dec-2024 ShareCast

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

STX Market Data

Currency UK Pounds
Share Price 2.35p
Change Today -0.050p
% Change -2.08 %
52 Week High 5.34
52 Week Low 1.60
Volume 1,287,198
Shares Issued 1,041.69m
Market Cap £24.48m
Beta 0.05

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.23% below the market average13.23% below the market average13.23% below the market average13.23% below the market average13.23% below the market average
74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average
Price Trend
26.74% below the market average26.74% below the market average26.74% below the market average26.74% below the market average26.74% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Income Not Available
Growth
62.41% above the market average62.41% above the market average62.41% above the market average62.41% above the market average62.41% above the market average
80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average80.65% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 16-May-2025

Time Volume / Share Price
14:50 32,783 @ 2.43p
13:43 15,000 @ 2.28p
13:01 15,000 @ 2.48p
12:50 410,784 @ 2.35p
12:29 9,874 @ 2.35p

STX Key Personnel

CEO Anders Lundstrom

Top of Page